Khokhar, Dr. Sarfraz – Trademark Portfolio
Entity Type: 01
Khokhar, Dr. Sarfraz holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 4 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include X, SUREFIZ, THE SECRET SAUCE TO WEIGHT LOSS, and REALISTIC INTELLIGENCE, NO MORE ARTIFICIAL. The owner is based in Raleigh, NC.
6521 Englehardt Drive
Raleigh, NC 27617
Showing of trademarks Trademarks
Trademark Classifications
Khokhar, Dr. Sarfraz's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Khokhar, Dr. Sarfraz have?
Khokhar, Dr. Sarfraz has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.
What trademark classes does Khokhar, Dr. Sarfraz file in?
Khokhar, Dr. Sarfraz files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Khokhar, Dr. Sarfraz's most well-known trademarks?
Khokhar, Dr. Sarfraz's registered trademark portfolio includes well-known marks such as X, SUREFIZ, THE SECRET SAUCE TO WEIGHT LOSS, and REALISTIC INTELLIGENCE, NO MORE ARTIFICIAL. These are among 4 currently registered trademarks in the portfolio.
What is Khokhar, Dr. Sarfraz's trademark registration success rate?
Khokhar, Dr. Sarfraz has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.